Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service
"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS
Ergebnis verändern
- Publikationstyp
Publikationstyp- Thema
- erschienen in
- Verlag
- Geographic terms
- Sprache
-
1
von Sandeep Sehdev ; Anil Abraham Joy ; Jean-François Boileau ; et al.
Current Oncology, Vol 33, Iss 2, p 112 (2026)
Schlagworte: hormone receptor-positive breast cancer; HER2-negative; early breast cancer; endocrine therapy; chemotherapy; CDK4/6 inhibitor; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
2
von Katarzyna J. Jerzak ; Aalok Kumar ; Jean-François Boileau ; et al.
Current Oncology, Vol 33, Iss 2, p 106 (2026)
Schlagworte: HR+ HER2− metastatic; advanced; breast cancer; Canadian consensus recommendations; evidence-based; REAL Alliance; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
3
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
-
4
von Jeffrey Q. Cao ; Brae Surgeoner ; Mita Manna ; et al.
Current Oncology, Vol 31, Iss 11, Pp 7226-7243 (2024)
Schlagworte: breast cancer; staging; recommendations; REAL Alliance; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
5
von Mita Manna ; Karen A. Gelmon ; Jean-François Boileau ; et al.
Current Oncology, Vol 31, Iss 11, Pp 6536-6567 (2024)
Schlagworte: HER2+; breast cancer; Canadian consensus recommendations; evidence-based; REAL Alliance; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
6
von Sharon F. McGee ; Mark Clemons ; Gregory Pond ; et al.
Current Oncology, Vol 31, Iss 8, Pp 4531-4545 (2024)
Schlagworte: breast cancer; endocrine therapy; radiotherapy; treatment sequence; toxicity; quality of life; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
7
von David J. Stewart ; John-Peter Bradford ; Sandeep Sehdev ; et al.
Current Oncology, Vol 31, Iss 5, Pp 2453-2480 (2024)
Schlagworte: drug costs; drug value; ICER; QALY; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
8
von Sandeep Sehdev ; Joanna Gotfrit ; Martine Elias ; et al.
Current Oncology, Vol 31, Iss 3, Pp 1460-1469 (2024)
Schlagworte: cancer; oncology; access; funding; drugs; reimbursement; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
9
von Sandeep R. Sehdev ; Nigel S. B. Rawson ; Olexiy I. Aseyev ; et al.
Current Oncology, Vol 31, Iss 4, Pp 1803-1816 (2024)
Schlagworte: oncology drugs; health technology assessment; drug prices; drug access; Canada; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
10
von Cazap, Eduardo ; Anderson, Benjamin ; Curigliano, Giuseppe ; et al.
General Surgery, East Africa
Schlagworte: breast cancer; quality index; early detection; timely diagnosis; comprehensive management; healthcare systems strengthening; health equity; patient centricity; universal access to health; healthcare quality; treatment effectiveness; Surgery; Women's Health
-
11
von Katarzyna J. Jerzak ; Sandeep Sehdev ; Jean-François Boileau ; et al.
Current Oncology, Vol 32, Iss 8, p 444 (2025)
Schlagworte: CDK4/6 inhibitors; HR+, HER2− early breast cancer; adjuvant therapy; multidisciplinary care; practical recommendations; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
12
von Papp, Kim A. ; Puig, Luis ; Beecker, Jennifer ; et al.
Journal of the European Academy of Dermatology and Venereology ; ISSN 0926-9959 1468-3083
-
13
von Ng, Terry L ; Greenstreet, Peter ; Stober, Carol ; et al.
JNCI Cancer Spectrum ; volume 9, issue 5 ; ISSN 2515-5091
- 14
-
15
von Evan Weber ; Carlos A. Carmona-Gonzalez ; Melanie Boucher ; et al.
Current Oncology, Vol 32, Iss 6, p 290 (2025)
Schlagworte: breast cancer; germline genetic testing; Canada; recommendations; mainstreaming; BRCA1; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
16
von Katarzyna J. Jerzak ; Nathaniel Bouganim ; Christine Brezden-Masley ; et al.
Current Oncology, Vol 30, Iss 6, Pp 5425-5447 (2023)
Schlagworte: advanced breast cancer; CDK4/6 inhibitors; HR+/HER2–; mutational testing; treatment considerations; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
17
von Daniel Rayson ; Sonal Gandhi ; Anil A. Joy ; et al.
Current Oncology, Vol 30, Iss 5, Pp 5050-5053 (2023)
Schlagworte: n/a; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
18
von Kim A. Papp ; Barbara Melosky ; Sandeep Sehdev ; et al.
Dermatology and Therapy, Vol 13, Iss 4, Pp 867-889 (2023)
Schlagworte: Psoriasis; Malignancy; Solid tumours; Cancer; Medical education; Evidence-based dermatology; Dermatology; RL1-803
-
19
von Daniel Rayson ; Sonal Gandhi ; Anil A. Joy ; et al.
Current Oncology, Vol 29, Iss 12, Pp 9891-9895 (2022)
Schlagworte: breast cancer; HER2 positive; neoadjuvant; pertuzumab; access; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- 20
- 21
-
22
von McGee, Sharon ; AlZahrani, Mashari ; Stober, Carol ; et al.
In Journal of Bone Oncology April 2021 27
-
23
von Alan Kaplan ; David J. Stewart ; Gerald Batist ; et al.
Current Oncology, Vol 29, Iss 4, Pp 2504-2508 (2022)
Schlagworte: oncology; pharmacotherapy; funding; research; development; outcomes; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
24
von Sandeep Sehdev ; Alexandra Chambers
Current Oncology, Vol 29, Iss 3, Pp 1919-1931 (2022)
Schlagworte: health technology assessment; reassessment; drug access; drug reimbursement; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
25
von Charlie Yang ; Christine Brezden-Masley ; Anil Abraham Joy ; et al.
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag